Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Anticancer Research|May 1, 2007
Loss of tumour suppressor p16 expression in initial stages of oral oncogenesisEleftherios Vairaktaris, Christos Yapijakis, Amanda Psyrri, et al.
In Vivo (Athens, Greece)|November 21, 2007
EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesisEleftherios Vairaktaris, Sofia Loukeri, Stavros Vassiliou, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|November 21, 2007
Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathwayEleftherios Vairaktaris, Lambros Goutzanis, Georgios Kalokerinos, et al.
Anticancer Research|April 4, 2008
The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinomaEleftherios Vairaktaris, Christos Yapijakis, Zoe Serefoglou, et al.
In Vivo (Athens, Greece)|August 22, 2007
Diabetes does not influence oral oncogenesis through fibroblast growth factor receptorsEleftherios Vairaktaris, Lambros Goutzanis, Emeka Nkenke, et al.
In Vivo (Athens, Greece)|August 22, 2007
Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potentialEleftherios Vairaktaris, Lambros Goutzanis, Giorgos Kalokerinos, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancerEleftherios Vairaktaris, Christos Yapijakis, Christos Tsigris, et al.
American Journal of Hematology|July 20, 2007
The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancerEleftherios Vairaktaris, Christos Yapijakis, Emeka Nkenke, et al.
Anticancer Research|March 14, 2007
Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinomaEleftherios Vairaktaris, Christos Yapijakis, Spyridoula Derka, et al.
Anticancer Research|January 5, 2007
FGFR-2 and -3 play an important role in initial stages of oral oncogenesisEleftherios Vairaktaris, Vassilis Ragos, Christos Yapijakis, et al.
Pageof 3